Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. Sept. 3, 2018. Giulio Cerroni.

Executive Summary

Brain health imaging company IXICO says a new strategy of partnering with smaller biotech companies, whilst still not forgetting big pharma, has helped drive growth for the business in 2018. See what company CEO Giulio Cerroni said about it here.

"Historically we worked a lot with the big pharma companies which we continue to do, but we’ve also started to work with more biotech companies. This is part of our drive to innovate and explore new approaches. As smaller companies, they usually don’t have some of the internal resources the big companies have, so that’s where a small company like us can really benefit business-wise." – Giulio Cerroni, CEO, IXICO

Click here for a free trial of Medtech Insight


Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts